Journal article · 2018
PRO labeling for oncology drugs approved by FDA and EMA, 2012-2016.
Journal of Clinical Oncology, 36(15_suppl), e18730 · Published 20 May 2018 · DOI 10.1200/jco.2018.36.15_suppl.e18730
In brief
“PRO labeling for oncology drugs approved by FDA and EMA, 2012-2016.” is a 2018 journal article by Ari Gnanasakthy and 3 co-authors, published in Journal of Clinical Oncology. OpenAlex counts 0 citations as of 22 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 0
- Authors
- 4
Abstract
e18730 Background: Although both the FDA and EMA note the importance of patient-reported outcomes (PROs) in oncology drug development, a recently published comparison of new drugs approved by these agencies between 2006 and 2010 found the EMA more likely than the FDA to grant PRO labeling claims (Gnanasakthy et al., 2017). The objective of this… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Gnanasakthy, A., Barrett, A. M., Evans, E., & D’Alessio, D. (2018). PRO labeling for oncology drugs approved by FDA and EMA, 2012-2016. Journal of Clinical Oncology, 36(15_suppl), e18730. https://doi.org/10.1200/jco.2018.36.15_suppl.e18730
MLA 9
Gnanasakthy, Ari, et al. “PRO labeling for oncology drugs approved by FDA and EMA, 2012-2016.” Journal of Clinical Oncology, vol. 36, no. 15_suppl, 2018, p. e18730. https://doi.org/10.1200/jco.2018.36.15_suppl.e18730.
Chicago
Gnanasakthy, Ari, Amy M Barrett, Emily Evans, and Denise D’Alessio. 2018. “PRO labeling for oncology drugs approved by FDA and EMA, 2012-2016.” Journal of Clinical Oncology 36 (15_suppl): e18730. https://doi.org/10.1200/jco.2018.36.15_suppl.e18730.
Harvard
Gnanasakthy, A. et al. (2018) ‘PRO labeling for oncology drugs approved by FDA and EMA, 2012-2016.’, Journal of Clinical Oncology, 36(15_suppl), p. e18730. doi:10.1200/jco.2018.36.15_suppl.e18730.
IEEE
A. Gnanasakthy, A. M. Barrett, E. Evans, and D. D’Alessio, “PRO labeling for oncology drugs approved by FDA and EMA, 2012-2016.,” Journal of Clinical Oncology, vol. 36, no. 15_suppl, p. e18730, 2018, doi: 10.1200/jco.2018.36.15_suppl.e18730.
BibTeX
@article{gnanasakthy2018labeling,
title = {{PRO labeling for oncology drugs approved by FDA and EMA, 2012-2016.}},
author = {Gnanasakthy, Ari and Barrett, Amy M and Evans, Emily and D’Alessio, Denise},
journal = {Journal of Clinical Oncology},
year = {2018},
volume = {36},
number = {15_suppl},
pages = {e18730},
doi = {10.1200/jco.2018.36.15_suppl.e18730},
url = {https://doi.org/10.1200/jco.2018.36.15_suppl.e18730}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- patient-reported outcomes
- drug labeling
- oncology drug approval
- FDA
- EMA
- regulatory submissions
- health-related quality of life
- content validity
Work with this paper
Most-cited papers in Economics, Econometrics and Finance
- Theory of the firm: Managerial behavior, agency costs and ownership structureMichael C. Jensen, William H. Meckling · Journal of Financial Economics · 1976 · 77,585 citations
- Institutions, Institutional Change and Economic PerformanceDouglass C. North · Cambridge University Press eBooks · 1990 · 34,377 citations
- The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.John E. Ware, Cathy Donald Sherbourne · PubMed · 1992 · 33,943 citations
- Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment EquationsManuel Arellano, Stephen R. Bond · The Review of Economic Studies · 1991 · 33,778 citations
- Co-Integration and Error Correction: Representation, Estimation, and TestingRobert F. Engle, C.W.J. Granger · Econometrica · 1987 · 32,847 citations
Questions about this paper
How do I cite this paper in APA style?
Gnanasakthy, A., Barrett, A. M., Evans, E., & D’Alessio, D. (2018). PRO labeling for oncology drugs approved by FDA and EMA, 2012-2016. Journal of Clinical Oncology, 36(15_suppl), e18730. https://doi.org/10.1200/jco.2018.36.15_suppl.e18730
How many times has this paper been cited?
0 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Ari Gnanasakthy, Amy M Barrett, Emily Evans, Denise D’Alessio.
What is the DOI of this paper?
10.1200/jco.2018.36.15_suppl.e18730, permanently at https://doi.org/10.1200/jco.2018.36.15_suppl.e18730. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.